Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections

Fig. 5

Methods and advantages of encapsulation by bacteriophages for therapeutic use. A Phage encapsulation methods. B Benefits of encapsulating phages for therapy versus the deployment of freely diffusing phages, including "protection" from conditions that inactivate the phage; "stability" during storage or administration of phages; "active site delivery" facilitation; and guaranteed "availability" to retain the phage at the site of infection and allow interaction with tissues to achieve "adhesion." (Reproduced with permission from [195])

Back to article page